These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
345 related items for PubMed ID: 16049563
1. Diagnostic capabilities of I-131, TI-201, and Tc-99m-MIBI scintigraphy for metastatic differentiated thyroid carcinoma after total thyroidectomy. Fujie S, Okumura Y, Sato S, Akaki S, Katsui K, Himei K, Takemoto M, Kanazawa S. Acta Med Okayama; 2005 Jun; 59(3):99-107. PubMed ID: 16049563 [Abstract] [Full Text] [Related]
4. Technetium-99m methoxyisobutylisonitrile imaging in the follow-up of differentiated thyroid carcinoma. Sriprapaporn J, Toopmongkol C, Satayaban B, Chantamoon N. Ann Acad Med Singap; 2002 Mar; 31(2):195-8. PubMed ID: 11957557 [Abstract] [Full Text] [Related]
5. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery. Rubello D, Mazzarotto R, Casara D. Eur J Nucl Med; 2000 Apr; 27(4):431-40. PubMed ID: 10805117 [Abstract] [Full Text] [Related]
6. Comparison of 99mTc-methoxyisobutyl isonitrile and 201Tl scintigraphy for detection of residual thyroid cancer after 131I ablative therapy. Seabold JE, Gurll N, Schurrer ME, Aktay R, Kirchner PT. J Nucl Med; 1999 Sep; 40(9):1434-40. PubMed ID: 10492361 [Abstract] [Full Text] [Related]
7. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy. Lind P, Gallowitsch HJ. Acta Med Austriaca; 1996 Sep; 23(1-2):69-75. PubMed ID: 8767519 [Abstract] [Full Text] [Related]
8. Clinical utility of technetium-99m methoxisobutylisonitrile imaging in differentiated thyroid carcinoma: comparison with thallium-201 and iodine-131 Na scintigraphy, and serum thyroglobulin quantitation. Dadparvar S, Chevres A, Tulchinsky M, Krishna-Badrinath L, Khan AS, Slizofski WJ. Eur J Nucl Med; 1995 Nov; 22(11):1330-8. PubMed ID: 8575487 [Abstract] [Full Text] [Related]
10. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma. Alam MS, Takeuchi R, Kasagi K, Misaki T, Miyamoto S, Iida Y, Hidaka A, Konishi J. Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573 [Abstract] [Full Text] [Related]
11. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma. Gallowitsch HJ, Mikosch P, Kresnik E, Unterweger O, Gomez I, Lind P. J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591 [Abstract] [Full Text] [Related]
12. [Evaluation of technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid cancer--comparison study with 131I and 201Tl]. Nagamachi S, Jinnouchi S, Nishii R, Flores LG, Nakahara H, Futami S, Tamura S, Toshimori H, Kawai K. Kaku Igaku; 2000 Mar; 37(2):89-98. PubMed ID: 10783567 [Abstract] [Full Text] [Related]